UK announces full inquiry into medicines shortages
This article was originally published in Scrip
Executive Summary
UK medicine shortages of brand name prescription drugs, which the pharmaceutical industry has attributed to parallel trade, are to be the subject of a major inquiry, says the All-Party Pharmacy Group, made up of members of the House of Commons and the House of Lords from various political parties.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.